Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14879-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14879-1-AP, RRID:AB_2067644
- Product name
- BTG1 antibody
- Antibody type
- Polyclonal
- Description
- BTG1 antibody (Cat. #14879-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Prognostic value of BTG1 for predicting decitabine sensitivity in de novo acute myeloid leukemia.
HIGD1A Alleviates Oxidative Stress Related Ovarian Hypofunction by Enhancing Granulosa Cell Functions via NF-κB/SOD2 Signaling Pathway.
Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
Exosomal microRNA-301a-3p promotes the proliferation and invasion of nasopharyngeal carcinoma cells by targeting BTG1 mRNA.
YWHAZ interacts with DAAM1 to promote cell migration in breast cancer.
BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial-Mesenchymal Transition.
miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.
Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1.
B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.
Zhang S, Li M, Xu B, Zhu X, Mao X, Zhou H, Tong X, Su S, Zhu Y, Zhang D
iScience 2026 Jan 16;29(1):114327
iScience 2026 Jan 16;29(1):114327
HIGD1A Alleviates Oxidative Stress Related Ovarian Hypofunction by Enhancing Granulosa Cell Functions via NF-κB/SOD2 Signaling Pathway.
Li H, Cai S, Mu H, Chang T, Wang X, Tang T, Dong T, Zhang Y, Zhang L, Li H, Zhou L, Xiang W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Sep;12(34):e03828
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Sep;12(34):e03828
Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
Zhong J, Shen X, Zhou J, Yu H, Wang B, Sun J, Wang J, Liu F
Frontiers in oncology 2023;13:1077342
Frontiers in oncology 2023;13:1077342
Exosomal microRNA-301a-3p promotes the proliferation and invasion of nasopharyngeal carcinoma cells by targeting BTG1 mRNA.
Cheng Q, Li Q, Xu L, Jiang H
Molecular medicine reports 2021 May;23(5)
Molecular medicine reports 2021 May;23(5)
YWHAZ interacts with DAAM1 to promote cell migration in breast cancer.
Mei J, Liu Y, Yu X, Hao L, Ma T, Zhan Q, Zhang Y, Zhu Y
Cell death discovery 2021 Aug 27;7(1):221
Cell death discovery 2021 Aug 27;7(1):221
BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial-Mesenchymal Transition.
Zhao S, Xue H, Hao CL, Jiang HM, Zheng HC
Frontiers in oncology 2020;10:598192
Frontiers in oncology 2020;10:598192
miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.
Su C, Huang DP, Liu JW, Liu WY, Cao YO
Oncology letters 2019 Sep;18(3):2825-2834
Oncology letters 2019 Sep;18(3):2825-2834
Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1.
Xu Y, Zhang G, Zou C, Gong Z, Wang S, Liu J, Ma G, Liu X, Zhang W, Jiang P
Journal of cellular physiology 2019 Jul;234(7):11999-12010
Journal of cellular physiology 2019 Jul;234(7):11999-12010
B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
Sun G, Liu Q, Cheng Y, Hu W
International journal of molecular medicine 2015 Mar;35(3):777-83
International journal of molecular medicine 2015 Mar;35(3):777-83
BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC, Li J, Shen DF, Yang XF, Zhao S, Wu YZ, Takano Y, Sun HZ, Su RJ, Luo JS, Gou WF
Oncotarget 2015 Aug 14;6(23):19685-705
Oncotarget 2015 Aug 14;6(23):19685-705
BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.
Zhao Y, Gou WF, Chen S, Takano Y, Xiu YL, Zheng HC
International journal of molecular sciences 2013 Sep 27;14(10):19670-80
International journal of molecular sciences 2013 Sep 27;14(10):19670-80
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The BTG1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human BTG1. This antibody recognizes human, mouse, rat antigen. The BTG1 antibody has been validated for the following applications: ELISA, IHC analysis.
